The Improving Outcomes in the Treatment of Opioid Dependence (IOTOD) 2018 conference was supported by various financial supporters.
Improving Outcomes in the Treatment of Opioid Dependence (IOTOD) 2018 was supported by an educational grant from Indivior. The session entitled “Tools for tackling opioid overdoses” was supported by an educational grant from Mundipharma International Ltd. The session entitled “Achieving HCV elimination” was supported by sponsorship from Gilead Sciences and an unrestricted grant from Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.
The educational programme is run at arm’s length from the financial supporters and all content is created by the faculty. No funder has had input into the content of the materials or presentations used in the educational programme. PCM Scientific is the medical education company acting as scientific secretariat and conference organiser. The session “Achieving HCV elimination” was developed in partnership with The International Network on Hepatitis in Substance Users (INHSU).